FDA2003年批准用生长素治疗健康但最矮的1，2% 的孩子。国内也跟进。治疗效果看人。

FDA2003年批准用生长素治疗健康但最矮的1，2% 的孩子。国内也跟进。治疗效果看人。治疗前很难预知谁效果会好。平均增长1.6到2.4英寸。 基本上无法改变偏矮的事实。 长期肿瘤副作用目前不清楚。 很有争议。但还是有家长愿意试。 目前儿童内分泌科仔细evaluate后才能决定是否用。

FDA 2003 年approved growth hormone (GH) to promote accelerated growth and adult height in the shortest 1.2% of children and adolescents who do not have any detectable medical problems. GH had previously been approved for treating youths with GH deficiency; in this case, medication was substituting for a hormone that these children’s bodies were not producing on their own. GH was then given to children with other medical conditions; for example, Prader-Willi in which metabolic benefits from treatment have been reported.